Gastrointestinal stromal tumours (GIST) in kidney transplant recipients ...

2 downloads 0 Views 141KB Size Report
Feb 3, 2007 - for CD117 (1:50, Dako) and variably for CD34 (1:200,. Zymed), but were negative for smooth muscle actin, desmin,. S100 and HHV8 (1:25, ...
Nephrol Dial Transplant (2007) 22: 1489

1489

4. Chigh KS, Sakhuia V, Jain S et al. High mortality in systemic fungal infections following renal transplantation in third-world countries. Nephrol Dial Transplant 1993; 8: 168–172 5. Villanueva A, Gotuzzo E, Arathoon E et al. A randomized double-blind study of caspofungin versus fluconazole for the treatment of oesophageal candidiasis. Am J Med 2002; 113: 294–299 6. Pfaller MA, Boyken L, Hollis RJ, Messer SA, Tendolkar S, Diekema DJ. In vitro susceptibilities of Candida spp. To Caspofungin: four years of global surveillance. J Clin Microbiol 2006; 44: 760–763 7. Arathoon EG, Gotuzzo E, Noriega LM, Berman RS, DiNubile MJ, Sable A. Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases. Antimicrob Agents Chemother 2002; 46: 451–457 doi:10.1093/ndt/gfl749

Advance Access publication 3 February 2007

Gastrointestinal stromal tumours (GIST) in kidney transplant recipients—a report of two cases Sir, Gastrointestinal stromal tumours (GIST) represent the most common primary mesenchymal GI neoplasms. GISTs occur in the stomach (60%), small intestine (30%), duodenum (5%), colorectum (

Suggest Documents